Stonepine Capital Management, LLC Q3 2023 significant ownership

Add to watchlist

Stonepine Capital Management, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Stonepine Capital Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CTI BIOPHARMA CORPApril 13, 20237,018,0465.3%
ADMA BIOLOGICS, INC.February 13, 20236,940,0003.1%
Amryt Pharma plcFebruary 13, 202331,666,1959.9%
Apollo Endosurgery, Inc.February 13, 20234,351,0889.0%
Conformis IncFebruary 13, 2023748,1949.9%
Ovid Therapeutics Inc.Sold outFebruary 13, 202300.0%
Adamas Pharmaceuticals IncSold outFebruary 14, 202200.0%
CATALYST BIOSCIENCES, INC.Sold outFebruary 14, 202200.0%
Conformis IncFebruary 14, 202214,768,8237.9%
YUMANITY THERAPEUTICS, INC.Sold outFebruary 14, 202200.0%
APPLIED GENETIC TECHNOLOGIES CORPSold outFebruary 11, 202200.0%
AYTU BIOPHARMA, INCSold outFebruary 11, 202200.0%
DiaMedica Therapeutics Inc.February 11, 20221,194,6704.5%
CHIASMA, INCSold outAugust 09, 202100.0%
Strongbridge Biopharma plcJuly 09, 20213,566,9645.3%
Affimed N.V.February 12, 2021219,3400.2%
Aptevo Therapeutics Inc.February 12, 202118,2800.4%
Baudax Bio, Inc.Sold outFebruary 12, 202100.0%
Cidara Therapeutics, Inc.Sold outFebruary 12, 202100.0%
CUMBERLAND PHARMACEUTICALS INCFebruary 12, 2021188,7031.3%
HTG MOLECULAR DIAGNOSTICS, INCSold outFebruary 12, 202100.0%
INTERPACE BIOSCIENCES, INC.Sold outFebruary 12, 202100.0%
IVERIC bio, Inc.February 12, 2021800,0000.9%
Neos Therapeutics, Inc.February 12, 20214,962,65710.0%
OPIANT PHARMACEUTICALS, INC.Sold outFebruary 12, 202100.0%
Aptevo Therapeutics Inc.February 13, 20204,561,60510.0%
BIODELIVERY SCIENCES INTERNATIONAL INCSold outFebruary 13, 202000.0%
CATABASIS PHARMACEUTICALS INCFebruary 13, 2020390,0003.3%
HTG MOLECULAR DIAGNOSTICS, INCFebruary 13, 20205,913,81210.0%
NOVELION THERAPEUTICS INC.February 13, 20203,909,20719.9%
VIVEVE MEDICAL, INC.Sold outJuly 23, 201900.0%
ALIMERA SCIENCES INCFebruary 13, 20196,547,7749.3%
Alphatec Holdings, Inc.February 13, 20191,147,8022.6%
BIOSPECIFICS TECHNOLOGIES CORPFebruary 13, 2019217,3953.0%
CANCER GENETICS, INCSold outFebruary 13, 201900.0%
Correvio Pharma Corp.February 13, 2019424,1011.2%
MELINTA THERAPEUTICS, INC. /NEW/Sold outFebruary 13, 201900.0%
Ophthotech Corp.February 13, 20194,072,3019.9%
SCYNEXIS INCFebruary 13, 2019568,4501.2%
CATABASIS PHARMACEUTICALS INCJune 28, 20184,800,0006.5%
SteadyMed Ltd.May 11, 20181,381,6515.2%
Recro Pharma, Inc.March 21, 201894,1820.5%
Cardiome Pharma CorpFebruary 13, 20183,195,6929.2%
CombiMatrix CorpSold outFebruary 13, 201800.0%
Vericel CorpSold outFebruary 13, 201800.0%
VICAL INCFebruary 13, 2018676,2323.6%
PAIN THERAPEUTICS INCSold outFebruary 14, 201700.0%
PERNIX THERAPEUTICS HOLDINGS, INC.Sold outFebruary 14, 201700.0%
TRINITY BIOTECH PLCFebruary 14, 2017436,0661.8%
Vanda Pharmaceuticals Inc.January 26, 20162,017,9004.7%

Compare quarters

Export Stonepine Capital Management, LLC's holdings

CSVXLS